×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Healt... [4]
Institute of Chi... [3]
THE STATE KEY LA... [3]
INSTITUTE OF COL... [1]
Authors
KWOK HANG FAI [1]
LU JINJIAN [1]
CHEN XIUPING [1]
JOONG SUP SHIM [1]
OUYANG DEFANG [1]
YU HUA [1]
More...
Document Type
Journal article [3]
Review article [2]
Other [1]
Date Issued
2024 [1]
2023 [1]
2022 [2]
2019 [1]
2016 [1]
Language
英語English [5]
Source Publication
Frontiers in Pha... [2]
Anti-Cancer Agen... [1]
MOLECULES [1]
Molecular Pharma... [1]
PHARMACOLOGICAL ... [1]
Indexed By
SCIE [5]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-6 of 6
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Author Ascending
Author Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Title Ascending
Title Descending
Submit date Ascending
Submit date Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Self-Assembled Micelles Based on Ginsenoside Rg5 for the Targeted Treatment of PTX-Resistant Tumors
Journal article
Gao, Feiyan, Ma, Zhongyi, Luo, Xing, Wang, Yahua, Liu, Xinlong, Tang, Mei, Chen, Junyu, Tu, Liangxing, Ouyang, Defang, Zheng, Ji, Li, Chong. Self-Assembled Micelles Based on Ginsenoside Rg5 for the Targeted Treatment of PTX-Resistant Tumors[J]. Molecular Pharmaceutics, 2024, 21(7), 3502-3512.
Authors:
Gao, Feiyan
;
Ma, Zhongyi
;
Luo, Xing
;
Wang, Yahua
;
Liu, Xinlong
; et al.
Favorite
|
TC[WOS]:
1
TC[Scopus]:
1
IF:
4.5
/
4.6
|
Submit date:2024/07/04
Chemotherapy Resistance
Paclitaxel
Paclitaxel-ginsenoside Micelles
Prostate Cancer Treatment
Severe Neurotoxicity
Editorial: New mechanistic insights into cancer precision medicine
Other
2023-02-16
Authors:
Kwok,Hang Fai
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
|
Submit date:2023/08/03
Immunotherapy
Targeted Therapy
Therapeutic Antibody
Chemotherapy
Novel Bioactive Molecule
Biomarker
Drug Resistance
Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer
Journal article
Xie Ying, Feng SenLing, He Fang, Yan PeiYu, Yao XiaoJun, Fan XingXing, Leung Elaine Lai Han, Zhou Hua. Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer[J]. PHARMACOLOGICAL RESEARCH, 2022, 186, 106514.
Authors:
Xie Ying
;
Feng SenLing
;
He Fang
;
Yan PeiYu
;
Yao XiaoJun
; et al.
Favorite
|
TC[WOS]:
18
TC[Scopus]:
17
IF:
9.1
/
9.0
|
Submit date:2023/01/30
Drug Resistance
Chemotherapy
Egfr Tyrosine Kinase Inhibitors
Nrf2
Tangeretin
Research Progress on Natural Diterpenoids in Reversing Multidrug Resistance
Review article
2022
Authors:
Zhuo-fen Deng1
;
Irina Bakunina
;
Hua Yu
;
Jaehong Han
;
Alexander Dömling
; et al.
Favorite
|
TC[WOS]:
2
TC[Scopus]:
2
IF:
4.4
/
5.0
|
Submit date:2022/08/29
Cancer
Chemotherapy
Multidrug Resistance
Natural Products
Diterpenoids
Establishment and characterization of pemetrexed-resistant NCI-H460/PMT cells
Journal article
Xu,Yu Lian, Jiang,Xiao Ming, Zhang,Le Le, Chen,Xiuping, Huang,Zhang Jian, Lu,Jin Jian. Establishment and characterization of pemetrexed-resistant NCI-H460/PMT cells[J]. Anti-Cancer Agents in Medicinal Chemistry, 2019, 19(6), 731-739.
Authors:
Xu,Yu Lian
;
Jiang,Xiao Ming
;
Zhang,Le Le
;
Chen,Xiuping
;
Huang,Zhang Jian
; et al.
Favorite
|
TC[WOS]:
4
TC[Scopus]:
5
IF:
2.6
/
2.5
|
Submit date:2021/03/01
Abcb1
Chemotherapy
Nsclc
Pemetrexed
Resistance
Tyms
Targeting epithelial-mesenchymal transition (EMT) to overcome drug resistance in cancer
Review article
2016
Authors:
Bowen Du
;
Joong Sup Shim
Favorite
|
TC[WOS]:
594
TC[Scopus]:
625
IF:
4.2
/
4.6
|
Submit date:2019/01/24
Epithelial–mesenchymal Transition
Drug Resistance
Chemotherapy
Cancer Stem Cells